In patients with end-stage renal disease, LRG1 significantly correlates with other markers of inflammation such as IL-6 and hsCRP, as well as T cell immunosenescence, and increased LRG1 levels are independently associated with the presence of peripheral arterial occlusive disease and cardiovascular disease [125]. Here, LRG1 is linked to stage 5 chronic kidney disease.